Press Releases

Feb 07, 2005 HEMISPHERX BIOPHARMA EXPANDS EVALUATION OF ALFERON N AGAINST AVIAN FLU

Jan 03, 2005 HEMISPHERX BIOPHARMA INITIATES ENROLLMENT IN HIV/HEP-C CLINICAL PROGRAM

Dec 27, 2004 HEMISPHERX BIOPHARMA FILES LAWSUIT IN FEDERAL COURT ALLEGING CONSPIRACY BY FOREIGN NATIONALS TO MANIPULATE ITS STOCK PRICE AND ENGAGE IN ILLEGAL HOSTILE TAKEOVER

Dec 21, 2004 Los Angeles Times Article Focuses on Hemispherx Biopharma's Experimental Drug Ampligen as a Potential New Therapy for Chronic Fatigue Syndrome

Nov 22, 2004 HEMISPHERX BIOPHARMA INITIATES ALFERON LDO® CLINICAL PROGRAM IN COLLABORATION WITH PRINCESS MARGARET HOSPITAL IN HONG KONG

Nov 12, 2004 HEMISPHERX BIOPHARMA THIRD QUARTER 2004 EARNINGS ANNOUNCED

Nov 08, 2004 HEMISPHERX BIOPHARMA TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 8TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE

Nov 01, 2004 Hemispherx Biopharma Presented New Data at the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, D.C.

Oct 25, 2004 HEMISPHERX BIOPHARMA TO PRESENT AT THE RODMAN & RENSHAW TECHVEST 6TH ANNUAL HEALTHCARE CONFERENCE ON OCTOBER 27th

Oct 20, 2004 Unexpected Neurological Damage Spreads with West Nile Virus; Heightens Concern in Healthcare Community

57 58 59 60 61 62 63 64 65 66 67

<< < > >>